Top Section
Top Section
Executive is moving to more senior role
India is on track for a record year of IPOs. Global tech giants continue to plough capital into a fast-growing consumer economy that is investing heavily in ensuring it’s a major player — along with the US and China — in an AI-first world
◆ Deal finds demand despite arrest of South Korea's president ◆ High single digit concession left for investors ◆ Leads added spread to calm concerns
More articles
More articles
More articles
-
Thailand-based Kasikornbank’s Hong Kong branch and Malaysia’s RHB Bank navigated a crowded Asia bond market to bag a combined $900m. -
DBS Asia Capital has named Anuruk Karoonyavanich as its new CEO, with the appointment effective from October 1.
-
Debut issuer Jubilant Pharma ventured out to the international bond market on September 29, netting $300m from its first dollar-denominated transaction.
-
The chances of an off-cycle decision for A-shares to be included in MSCI’s Emerging Markets Index has increased after the index provider launched 20 new China equity indices on September 29 and praised Beijing’s recent reform efforts.
-
The names of banks backing Indian firm Intas Pharmaceutical’s bid for the UK and Ireland assets of Teva Pharmaceutical Industries have emerged.
-
The Asian green bond market has gone from being a minnow a year ago to dominating global issuance, proving that the product is here to stay. But with no real pricing advantage and the investor base still largely traditional, there is plenty holding back a shift towards growth and sophistication writes Rashmi Kumar.
shared comment list
